| Blepharitis |
Inflammation of the eyelids |
| Chalazion |
A cyst on the eyelid due to plugging of the meibomian glands, fat-secreting glands of the eyes |
| Comedone |
A plugged hair follicle. May be open (blackhead) or nearly closed (whitehead). |
| Controlled study |
An experiment or clinical trial that includes an untested comparison group, referred to as a "control group." |
| Cutaneous |
Pertaining to the skin |
| Double-blind |
A research procedure in which neither the patient nor the investigator knows who is receiving the experimental substance or procedure and who is receiving a placebo. Done to avoid bias in the study |
| Edema |
Swelling
from abnormally large amounts of fluids in the tissues |
| Erythema |
Abnormal redness of the skin |
| Erythematotelangiectatic rosacea |
Subtype 1 rosacea, characterized by flushing and persistent redness. Visible blood vessels may also appear |
| Flushing |
Transient redness of the face and neck |
| Granuloma |
A tumor-like mass or nodule of tissue |
| Granulomatous rosacea |
Variant of rosacea, characterized by hard yellow, brown or red papules or nodules. |
| Nodule |
A small node that is solid and can be detected by touch |
| Ocular rosacea |
Subtype 4 rosacea, characterized by watery or bloodshot appearance, irritation, burning or stinging of the eyes |
| Papule |
A small, dome-shaped, solid, usually inflamed elevation of the skin |
| Papulopustular rosacea |
Subtype 2 rosacea, characterized by facial redness with bumps or pimples. |
| Paranasal |
Alongside the nose |
| Phymatous rosacea |
Subtype 3 rosacea, characterized by thickening or growth of excess tissue, often around the nose |
| Placebo |
An oral or topical formulation without this active ingredient, used for comparison with the active medication in controlled clinical studies |
| Plaque |
Elevated red patch on the skin |
| Pustule |
A small elevation of the skin filled with a white substance |
| Recalcitrant |
Not responsive to treatment |
| Rhinophyma |
Enlargement of the nose with excess tissue, a common form of phymatous rosacea. |
| Subtype |
A common pattern or grouping of signs and symptoms |
| Subtype 1 rosacea |
Erythematotelangiectatic rosacea, characterized by flushing and persistent redness. Visible blood vessels may also appear. |
| Subtype 2 rosacea |
Papulopustular rosacea, characterized by facial redness with bumps or pimples. |
| Subtype 3 rosacea |
Phymatous rosacea, characterized by thickening or growth of excess tissue, often around the nose |
| Subtype 4 rosacea |
Ocular rosacea, characterized by watery or bloodshot appearance, irritation, burning or stinging of the eyes. |
| Telangiectasia |
Blood vessels visible through the skins |
| |
|